DG | Blue Horseshoe Stocks

Blue Horseshoe Stocks: RKDA Explodes & More

Arcadia Biosciences, Inc. RKDA

We originally put RKDA on our radars toward the end of January, but in the ensuing weeks, the stock mainly traded sideways.

This week, both Tuesday morning and yesterday, we included it on our watchlist once again as we noticed it was finally building up some momentum. Yesterday that momentum turned into an absolute explosion as RKDA blasted off to an astounding new high.

Just since Tuesday morning it has traded from a low of 11.17 to a new high of 54.9895 yesterday. That’s a two day swing of 370% and a mind numbing increase of 1244% over the 4.09 low we observed subsequent to our initial mention!

Valeant Pharma International, Inc. VRX

On Monday morning, we tagged the VRX Weekly $15 & $15.50 Calls, and after finding success with those as VRX continued to move, yesterday we expanded our target range to include the $16 and $16.50’s as well. After another bullish session, all of those ideas produced opportunities for big gains.

The $15’s from our observed low on Monday of .65, hit 2.21 for a gain of 240%, while the $15.50’s, from .30 reached 1.73, an increase of 477%

The $16 Calls ran from .35-1.24, for a single sessions rip of 254% and the $16.50’s traded in a range from .13 to .75, a 477% upswing.

Fresh Options Idea:
Dollar General Corp. DG Weekly $94-96.50 Calls

Extended Watchlist:
ABCD, ABEO, APRN, APTO, ONCS, EVEP, RUBI, XXII,

Blue Horseshoe Stocks: Post-Earnings Options & More

Dollar General Corp. DG

First up this morning is a look at DG, which revealed its Q3 earnings report early this morning, and appears to be gearing up for some continued bullish activity, for which we’ll want to formulate an options trading idea.

The stock has been in a general uptrend for many months, seeing its annual lows in June, and trading in a general upward channel ever since. DG is gapping up roughly 5% in premarket trading, and we’re going to look for action in the DG Weekly $93.50-96 Calls today and possibly tomorrow as well.

Lululemon Athletica

This is another stock that has put up a good performance since late spring. After seeing its own annual low at the end of May in the $66 area, LULU has recently breached the $90 mark.

That upward climb could continue on the heels of what was a solid beat on both sales and earnings in the post-market yesterday, as well as boosted sales guidance. When coupled with the $200M share repurchase the company has just authorized, and we have another excellent candidate for some options trading ideas. In this case we’re interested in tracking the LULU Weekly $72.50-74 Calls.

Extended Watchlist:
ROX, HOME, VTGN, IGC, MYO, CRSP, TLRD

Blue Horseshoe Stocks: Options, Bottom-Plays & More

Dollar General Corp. DG – Recap

After a beat on sales and profits for the quarter and a chart primed for a bullish move, we highlighted the DG Weekly $75-78 Calls and we’re happy to report that each and every one of the contracts contained within that range recorded huge intraday moves for us.

Regardless which set of the seven was chosen, multi-bag gains were there for the taking:

$75 Calls – Range: .92-3.10 – Max Gain: 237%
$75.50 Calls – Range: .64-.2.22 – Max Gain: 247%
$76 Calls – Range: .40-2.05 – Max Gain: 412%
$76.50 Calls – Range: .24-1.20 – Max Gain: 400%
$77 Calls – Range: .12-1.21 – Max Gain: 908%
$77.50 Calls – Range: .06-.80 – Max Gain: 1233%
$78 Calls – Range: .05-.45 – Max Gain: 800%

_______

Lululemon Athletica LULU – Fresh Ideas

Lululemon had an earnings beat of its own yesterday post-market, so we want to formulate some ideas for the LULU chain as well.

Not only is the stock gapping up on earnings, but like DG yesterday, the LULU chart was already looking like a bottom-play with premium potential. That’s why we want to formulate both a short and long term set of ideas for LULU options. The LULU Weekly $55-57.50 Calls*, to coincide with the immediate boost in activity off of these earnings, and the LULU 06/30 58.50-60.50 Calls in the event of a protracted recovery.

*We never highlight options with a weekly expiration on a Friday without an explicit warning. That should tell you how risky it can be. So if you’re not an expert trader, don’t even think about it!

Synergy Pharmaceuticals, Inc. SGYP

We also want to put SGYP on watch today after noticing that the stock is coming off of its 52-week lows. That’s always a chart setup that we’re going to look at, but in this case the lows followed shartly after the company producing positive Phase III data on its TRULANCE™ drug, which is already approved by the FDA.

We’ve included a chart snapshot here, and you can plainly see, the stock had been beaten back severely and is only just now beginning to mount a rebound.

Extended Watchlist:
DOLV, USRM, ICNB, ANW, CGG, ANTH